AHR Stock Analysis: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$46.87
0.40 (0.86%)
▲
5d:
+0.34%
30d:
-5.03%
90d:
-11.62%
HOLD
MODERATE Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.87
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.00
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $46.87, which is considered slightly low relative to its 30-day fair value range of $46.77 to $50.89. The stock's valuation (Forward PE: 54.5) is in line with its historical norms (60.2). Remarkably, the market is currently pricing in an annual earnings decline of 3.2% over the next few years. This pessimistic expectation contrasts with the company's recent 306.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $48.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $58.85 (+25.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $48.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $58.85 (+25.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$46.77 -
$50.89
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.6% below Wall St target ($58.85)
Trading Range Analysis
30-Day Trading Range
$46.77 -
$50.89
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$44.81
Resistance Level
$48.02
Current Trend
Strong Uptrend
Technical data as of
Jun 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
54.50
Wall Street Target
$58.85
(+25.6%)
Revenue Growth (YoY)
20.9%
Earnings Growth (YoY)
306.2%
Profit Margin
4.2%
Valuation Discount vs History
-3.2% cheaper
PE vs Historical
54.5 vs 60.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.2%
(market-implied from PE analysis)
1-Year Target
$45.37
(-3%)
2-Year Target
$43.92
(-6%)
3-Year Target
$42.51
(-9%)
3-Yr Target (if PE normalizes)
(PE: 55→60)
$46.96
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 54.5, Growth: 56.4%)
$158.19
(+238%)
Base:
(SPY PE: 21.8, Growth: 56.4%)
$63.22
(+35%)
Bear:
(PE: 18.5, Growth: 56.4%)
$53.73
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (79x PE), but valuation improves significantly next year (55x PE) as earnings recover.
Trailing PE: 78.76 | Current EPS (TTM): $0.59
Bull Case
$74.51
(+59%)
Analyst growth 45.8%, PE expands to 86.6
Base Case
$67.74
(+45%)
Market implied 45.8%, PE stable at 78.8
Bear Case
$31.60
(-33%)
Severe decline -20.0%, PE contracts to 67.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 54.5 to 60.2
Stabilization Target:
$51.77
(+10.5%)
PE Expansion Potential:
+10.5%
Share & Embed Analysis
Last updated: June 17, 2026 4:10 AM ET
Data refreshes hourly during market hours. Next update: 5:10 AM
Data refreshes hourly during market hours. Next update: 5:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark E Foster
SELL
2000 shares
2026-03-25
Jeffrey T Hanson
SELL
19208 shares
2025-12-23
Jeffrey T Hanson
SELL
35570 shares
2025-12-22
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$97 | 59 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$237 | 58 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$21 | 57 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 59 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
9 analysts |
$45 | 58 HOLD |
